Prediction of Cancer Incidence and Mortality in Korea, 2023

Purpose This study aimed to report the projected cancer incidence and mortality for the year 2023 to estimate Korea's current cancer burden. Materials and Methods Cancer incidence data from 1999 to 2020 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2021 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2023. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend. Results In total, 273,076 new cancer cases and 81,818 cancer deaths are expected to occur in Korea in 2023. The most common cancer site is expected to be the lung, followed by the thyroid, breast, colon and rectum, and stomach. These five cancers are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and gallbladder cancers. Conclusion The incidence rates for all types of cancer in Korea are estimated to gradually decrease. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.

Automated summary

This study aimed to estimate Korea's current cancer burden by reporting the projected cancer incidence and mortality for the year 2023. Cancer incidence and mortality were projected using a linear regression model and population data. It is estimated that there will be 273,076 new cancer cases and 81,818 cancer deaths in Korea in 2023. Lung cancer is expected to be the most common cancer site, followed by thyroid, breast, colon and rectum, and stomach cancers. The incidence rates for all types of cancer are estimated to gradually decrease in Korea. These estimates provide important information for planning and evaluating cancer control programs.